Grindelia squarrosa

Grindelia squarrosa · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Grindelia squarrosa is a versatile plant species frequently utilized for its therapeutic properties in traditional medicine. Derived primarily from its aerial parts, the plant contains unique chemical compounds such as grindelic acid. These substances exhibit significant pharmacological activities, including (-)-chronotropic, (-)-inotropic, analgesic, and allelochemic effects. Due to these characteristics, it is often employed to manage respiratory and systemic conditions like bronchitis, cough, fever, and influenza. This makes the plant a subject of interest for its diverse biological and medicinal potential.

Quick facts
Synonyms
Grindelia Serrulata · Grindelia Squarrosa Var. Serrulata · 11 more
Common names
Not available
Family
Asteraceae
Distribution
Not available
Plant Parts
Not available

Classification

Common Names

Grindelia squarrosa is a versatile plant known by many different names depending on the region and language. It is widely recognized by its common English names, such as Broadleaf Gumweed, Curlycup Gumweed, and simply Gumweed. In botanical contexts, it is also referred to as Grindelia szorstka. Culturally, the plant holds significance under the name Ch'ilbílátahaltsóíí. These diverse monikers reflect the widespread presence and varied recognition of this species across different landscapes.

Sources: Catalogue of Life (COL)

Synonyms

Grindelia squarrosa is a botanical species known to be associated with several different taxonomic synonyms. Throughout various scientific records, it has been referred to by the names Aurelia amplexicaulis and Aurelia squarrosa. The plant is also documented under the synonym Donia squarrosa in certain historical classifications. Additionally, researchers have utilized the names Grindelia angustifolia and Grindelia arguta to describe this same organism. Understanding these varied nomenclature relationships is essential for accurate botanical identification.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Grindelia squarrosa is a fascinating botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida, marking its place among diverse vascular plants. It further resides in the order Asterales, a group that showcases remarkable evolutionary traits. As a member of the family Asteraceae, it shares characteristics with many well-known flowering species. Finally, this plant is distinguished by its specific genus, Grindelia, which defines its unique biological identity.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Asterales
Family Asteraceae
Genus Grindelia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Grindelia squarrosa exhibits a broad geographical presence stretching across several diverse regions. In Asia, this plant is widely distributed throughout the temperate zones, including the Caucasus and Transcaucasus. Its reach extends further east into China and the Manchuria region, as well as the Russian Far East within Primorye. The species also maintains a significant foothold in Europe, specifically throughout the Baltic States. Additionally, its range encompasses parts of Eastern Europe, including Belarus.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Grindelia squarrosa is a self-supporting herb that grows with a sturdy and upright structure. This plant typically reaches a maximum height of 1 meter, though it can be found as small as 0.25 meters. Its growth form allows it to maintain its position effectively within its natural habitat. Overall, these dimensions characterize the modest yet resilient stature of this species.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Grindelia squarrosa serves as a significant botanical source for discovering potent anti-inflammatory compounds used in treating respiratory diseases. Research highlights that this plant contains grindelic acid, a specific component capable of modulating the body's immune response. This acid has demonstrated a significant ability to suppress the release of pro-inflammatory cytokines such as IL-8, TNF-α, and IL-1β. Such findings are particularly relevant because these biochemical markers play a central role in the pathophysiology of acute bronchitis and wheezing. Ultimately, the presence of grindelic acid within the plant justifies the traditional medicinal use of Grindelia squarrosa for managing inflammation-based respiratory conditions.

Conditions

Grindelia squarrosa is traditionally used in Europe as a medicinal plant to treat various respiratory tract conditions, including cough and bronchitis. Its active compounds provide significant anti-inflammatory activity that helps treat bronchial inflammation. By suppressing the release of key cytokines, the plant effectively aids in the treatment of acute bronchitis. Furthermore, its pharmacological properties are beneficial for managing acute wheezing disease. These combined effects justify its use as a natural remedy for several inflammation-based respiratory ailments.

Preparations

Grindelia squarrosa is prepared as aerial parts to serve as a potential source of anti-inflammatory compounds. These specific plant components were selected during a screening of medicinal plants traditionally used in Europe to treat respiratory tract diseases. Research indicates that these aerial parts contain active substances capable of limiting neutrophil migration in inflamed tissues. By utilizing these parts, scientists observed a significant suppression of pro-inflammatory cytokines like IL-8, TNF-α, and IL-1β. Consequently, the use of the aerial parts of Grindelia squarrosa provides a pharmacological basis for treating inflammation-based respiratory conditions.

Parts used